It always takes much longer than people think to evaluate results from a clinical trial, and that's particularly true in one like a psoriasis trial, where there is a certain subjective element to it. If there is still a lesion, how much smaller is it, what's the patient's discomfort level, etc. So I can see how it could take them quite a while to make sure the results accurately reflect the clinical trial's efficacy. No one wants to understate the efficacy, but making exaggerated claims would get a company into big trouble.
4th quarter starts in October so if your calculations are correct, they'd be looking at 6 weeks of analysis to get results out by Oct. 1. I think that's pushing it, but it wouldn't surprise me to see results in October or maybe early November if we're being overly optimistic about enrollment.
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links